Ovid Therapeutics
OVID
OVID
62 hedge funds and large institutions have $73.7M invested in Ovid Therapeutics in 2019 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 22 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
62
Holders Change
+24
Holders Change %
+63.16%
% of All Funds
1.22%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
29
Increased
22
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
+$12M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.65M |
| 3 |
Axa
Paris,
France
|
+$3.6M |
| 4 |
Citigroup
New York
|
+$2.07M |
| 5 |
Renaissance Technologies
New York
|
+$2.07M |
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$6.59M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$59K |
| 3 |
MWNA
Marshall Wace North America
New York
|
-$41K |
| 4 |
WG
Winton Group
London,
United Kingdom
|
-$34K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$32.8K |
